{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T06:28:13Z","timestamp":1770704893042,"version":"3.49.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1097\/rlu.0000000000001334","type":"journal-article","created":{"date-parts":[[2016,9,7]],"date-time":"2016-09-07T13:18:19Z","timestamp":1473254299000},"page":"e465-e472","source":"Crossref","is-referenced-by-count":9,"title":["Clinical Significance of Quantitative 123I-MIBG SPECT\/CT Analysis of Pheochromocytoma and Paraganglioma"],"prefix":"10.1097","volume":"41","author":[{"given":"Ryusuke","family":"Nakamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Ishimori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Togashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-23-20210204","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/RLU.0b013e31824c5f43","article-title":"Pheochromocytoma in multiple endocrine neoplasia type 2A: positive 123I MIBG with negative CT and equivocal 131I MIBG imaging","volume":"37","author":"Ishii","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R2-23-20210204","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2214\/AJR.12.9126","article-title":"Pheochromocytoma: the range of appearances on ultrasound, CT, MRI, and functional imaging","volume":"200","author":"Leung","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"R3-23-20210204","doi-asserted-by":"crossref","first-page":"839","DOI":"10.2967\/jnumed.115.154815","article-title":"Semiquantitative 123I-metaiodobenzylguanidine scintigraphy to distinguish pheochromocytoma and paraganglioma from physiologic adrenal uptake and its correlation with genotype-dependent expression of catecholamine transporters","volume":"56","author":"van Berkel","year":"2015","journal-title":"J Nucl Med"},{"key":"R4-23-20210204","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.2967\/jnumed.107.043281","article-title":"Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6\u201318F-fluorodopamine PET","volume":"48","author":"Timmers","year":"2007","journal-title":"J Nucl Med"},{"key":"R5-23-20210204","first-page":"1225","article-title":"Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging","volume":"9","author":"Nakatani","year":"2002","journal-title":"Oncol Rep"},{"key":"R6-23-20210204","first-page":"1599","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphy in localising phaeochromocytomas\u2014experience and meta-analysis","volume":"26","author":"Van Der Horst-Schrivers","year":"2006","journal-title":"Anticancer Res"},{"key":"R7-23-20210204","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2967\/jnumed.111.098152","article-title":"Modern nuclear imaging for paragangliomas: beyond SPECT","volume":"53","author":"Taieb","year":"2012","journal-title":"J Nucl Med"},{"key":"R8-23-20210204","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1007\/s00259-010-1545-7","article-title":"131I\/123I-metaiodobenzylguanidine (mIBG) scintigraphy: procedure guidelines for tumour imaging","volume":"37","author":"Bombardieri","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R9-23-20210204","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2967\/jnumed.112.111476","article-title":"An evidence-based review of quantitative SPECT imaging and potential clinical applications","volume":"54","author":"Bailey","year":"2013","journal-title":"J Nucl Med"},{"key":"R10-23-20210204","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/RLU.0b013e318263923d","article-title":"Intraindividual comparison of 123I-mIBG SPECT\/MRI, 123I-mIBG SPECT\/CT, and MRI for the detection of adrenal pheochromocytoma in patients with elevated urine or plasma catecholamines","volume":"38","author":"Derlin","year":"2013","journal-title":"Clin Nucl Med"},{"key":"R11-23-20210204","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.2967\/jnumed.110.078352","article-title":"Multicenter evaluation of a standardized protocol for rest and acetazolamide cerebral blood flow assessment using a quantitative SPECT reconstruction program and split-dose 123I-iodoamphetamine","volume":"51","author":"Iida","year":"2010","journal-title":"J Nucl Med"},{"key":"R12-23-20210204","first-page":"164280","article-title":"False positive radioiodinated metaiodobenzylguanidine ((123)I-MIBG) uptake in undifferentiated adrenal malignant tumor","volume":"2015","author":"Jung","year":"2015","journal-title":"Case Rep Oncol Med"},{"key":"R13-23-20210204","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000185010","article-title":"Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma. A false-positive case of adrenocortical adenoma and literature review","volume":"46","author":"Sone","year":"1996","journal-title":"Horm Res"},{"key":"R15-23-20210204","first-page":"576","article-title":"Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases","volume":"26","author":"Shapiro","year":"1985","journal-title":"J Nucl Med"},{"key":"R16-23-20210204","first-page":"1476","article-title":"Alterations of iodine-131 MIBG biodistribution in an anephric patient: comparison to normal and impaired renal function","volume":"30","author":"Tobes","year":"1989","journal-title":"J Nucl Med"},{"key":"R17-23-20210204","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/jc.2011-0333","article-title":"Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy","volume":"96","author":"King","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R18-23-20210204","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1530\/ERC-11-0243","article-title":"False-negative \u00b9\u00b2\u00b3I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease","volume":"19","author":"Fonte","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"R19-23-20210204","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"Timmers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"R20-23-20210204","first-page":"419","article-title":"Detection and treatment of pheochromocytomas and paragangliomas: current standing of MIBG scintigraphy and future role of PET imaging","volume":"52","author":"Havekes","year":"2008","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R21-23-20210204","first-page":"351","article-title":"Meta-iodobenzylguanidine and analogues: chemistry and biology","volume":"52","author":"Vaidyanathan","year":"2008","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"R22-23-20210204","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/jc.2009-2352","article-title":"6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression","volume":"95","author":"Fottner","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000001334","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T06:16:13Z","timestamp":1620972973000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201611000-00023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000001334","relation":{},"ISSN":["0363-9762"],"issn-type":[{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]}}}